Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gemcitabine Plus Carboplatin vs Carboplatin in Advanced Ovarian Cancer
NCT00102414Phase 3Completed
- Sponsor
- AGO Study Group
- Start
- Sep 1999
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of gemcitabine in ovarian cancer, sponsored by AGO Study Group. Started Sep 1999; status: completed.
02
Drugs
gemcitabine
03
Conditions
ovarian cancer
Beyond the preview
Go deeper on NCT00102414.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00102414.